People with type 2 diabetes are invited to join a study to test how well a new medicine, called CagriSema, works. CagriSema will be compared to another medicine called tirzepatide. Both medicines aim to lower blood sugar and help with weight loss. Participants will get one of the medicines by chance, like flipping a coin. The study will last up to 1 year and 4 months.

To join, you must be 18 or older, have type 2 diabetes for at least 6 months, and take certain diabetes medicines, like Metformin or SGLT2 inhibitors. Your HbA1c (a measure of blood sugar) should be between 7.0% and 10.5%. You need to have a body mass index (BMI) of 30 or higher.

Pregnant women, or those planning to become pregnant, cannot join. If you have kidney problems or other serious health issues, you may be excluded. You can't join if you've used certain other diabetes or weight-loss drugs recently.

• The study lasts for up to 1 year and 4 months.
• Participants will randomly receive either CagriSema or tirzepatide.
• Some medical conditions or recent drug use may prevent participation.